3/12
04:57 pm
fblg
FibroBiologics (FBLG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $7.00 price target on the stock.
Medium
Report
FibroBiologics (FBLG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $7.00 price target on the stock.
3/12
08:30 am
fblg
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
Low
Report
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
3/5
08:30 am
fblg
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
Medium
Report
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
3/2
08:30 am
fblg
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
High
Report
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
2/26
08:30 am
fblg
FibroBiologics to Present at the BIO Investment & Growth Summit
Medium
Report
FibroBiologics to Present at the BIO Investment & Growth Summit
2/26
07:17 am
fblg
FibroBiologics (FBLG) had its "buy" rating reaffirmed by HC Wainwright.
Low
Report
FibroBiologics (FBLG) had its "buy" rating reaffirmed by HC Wainwright.
2/25
04:45 pm
fblg
FibroBiologics (FBLG) had its price target lowered by D. Boral Capital from $15.00 to $7.00. They now have a "buy" rating on the stock.
Medium
Report
FibroBiologics (FBLG) had its price target lowered by D. Boral Capital from $15.00 to $7.00. They now have a "buy" rating on the stock.
2/24
04:30 pm
fblg
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Low
Report
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
5/14/2025
04:01 pm
fblg
fibrobiologics, inc.
MISS
Report
22.7%
fibrobiologics, inc.
3/13
04:21 pm
fblg
Form 10-K/A FibroBiologics, Inc. For: Dec 31
High
Report
Form 10-K/A FibroBiologics, Inc. For: Dec 31
3/6
04:04 pm
fblg
Form 8-K FibroBiologics, Inc. For: Mar 04
Medium
Report
Form 8-K FibroBiologics, Inc. For: Mar 04
3/5
08:00 am
fblg
Form 4 FibroBiologics, Inc. For: Mar 04 Filed by: Khoja Hamid
Medium
Report
Form 4 FibroBiologics, Inc. For: Mar 04 Filed by: Khoja Hamid
3/4
05:50 pm
fblg
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: O'HEERON PETE
High
Report
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: O'HEERON PETE
3/3
08:00 am
fblg
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: Davis Jason
Medium
Report
Form 4 FibroBiologics, Inc. For: Mar 02 Filed by: Davis Jason
3/2
09:15 am
fblg
Form 4 FibroBiologics, Inc. For: Feb 27 Filed by: GARCIA RUBEN A
High
Report
Form 4 FibroBiologics, Inc. For: Feb 27 Filed by: GARCIA RUBEN A
2/24
04:07 pm
fblg
Form 10-K FibroBiologics, Inc. For: Dec 31
Low
Report
Form 10-K FibroBiologics, Inc. For: Dec 31
2/23
04:19 pm
fblg
Form 8-K FibroBiologics, Inc. For: Feb 20
Medium
Report
Form 8-K FibroBiologics, Inc. For: Feb 20
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register